Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations

Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations

10.2174/157018006778631884

Saved in:
Bibliographic Details
Main Authors: Chiu, G.N.C., Harasym, T.O., Tardi, P.G., Bally, M.B., Waterhouse, D.N.
Other Authors: PHARMACY
Format: Article
Published: 2014
Subjects:
Combination therapy
Liposomes
Therapeutic antibodies
Online Access:http://scholarbank.nus.edu.sg/handle/10635/106183
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/106183

Similar Items